Investment in UK spinouts surged to a record £3.35 billion in 2024, a 44.3% increase on the previous year. A new report from Parkwalk Advisors, the UK’s leading university spinout investor, and analytics firm Beauhurst highlights the rebound in equity investment following a 2023 downturn.
The average equity raised jumped from £4.96 million in 2023 to £7.49 million in 2024, driven by strong investor interest in globally scalable companies.
Life Sciences led activity, with 182 deals in pharmaceuticals, biotech, and clinical research, while DeepTech—especially AI and data infrastructure—accounted for 152 deals, reflecting UK industrial priorities.
In H1 2025, UK spinouts raised £709 million across 175 deals, with momentum expected to pick up in H2. Despite economic headwinds, investor confidence remains strong, supported by world-class research and a growing founder base.